Yeah, I thought you might like that!
Hi Tig,
It's amusing what some guys do to get a paper to present at a Conference.
I've read some garbage articles but the Telaprevir vs Boceprevir one takes the cake.
We're looking at 17 patients who took Victrelis, with only 8 achieving SVR. The Rx length, fibrosis stage etc. are not mentioned.
Victrelis is the DAA of choice in Australia with SVR rates of 70-80%.
Thanks for providing some more light reading. Cheers.
A Healio.com article regarding information presented at: Digestive Disease Week 2014; May 3-6, 2014; Chicago
Re-treatment with Sofosbuvir, Interferon effective in GT 2 or 3
Telaprevir (Incivek) showed greater SVR, cost-effectiveness than Boceprevir (Victrelis) among HCV patients
Yeah, I thought you might like that!
Hi Tig,
It's amusing what some guys do to get a paper to present at a Conference.
I've read some garbage articles but the Telaprevir vs Boceprevir one takes the cake.
We're looking at 17 patients who took Victrelis, with only 8 achieving SVR. The Rx length, fibrosis stage etc. are not mentioned.
Victrelis is the DAA of choice in Australia with SVR rates of 70-80%.
Thanks for providing some more light reading. Cheers.
A Healio.com article regarding information presented at: Digestive Disease Week 2014; May 3-6, 2014; Chicago
Re-treatment with Sofosbuvir, Interferon effective in GT 2 or 3
Telaprevir (Incivek) showed greater SVR, cost-effectiveness than Boceprevir (Victrelis) among HCV patients